Atrantil

What Atrantil does

Atrantil is a privately held U.S. company that manufactures and sells digestive health supplement products. Founded in 2015 and headquartered in Dallas, Texas, the company operates at small-business scale with 11 to 50 employees and runs direct-to-consumer commerce through its website at atrantil.com. The business is founder-led by Kenneth Brown, whose name is associated with the brand identity. The firm's product category — digestive supplements — places it within the broader consumer health and nutraceuticals market, where revenue mechanics typically combine direct e-commerce sales with potential retail and practitioner channels (none of which are confirmed in the available input).

Available source data on operating details, financials, partnerships, distribution, and product specifications is sparse. The primary third-party source attempted returned only a loading/verification page with no substantive business content, leaving firmographic facts as the principal evidentiary base. No funding rounds, M&A activity, regulatory actions, leadership changes beyond the founder, subsidiary structure, or geographic footprint claims are documented in the supplied material. Consequently, the company's current revenue, channel mix, customer segmentation, and growth indicators cannot be triangulated from the data provided.

The investment-relevant read is that Atrantil is a small, founder-led, private nutraceutical brand with a nine-year operating history. Its principal asset is the brand itself and Kenneth Brown's continued association with it. Absent disclosed funding, distribution partnerships, clinical evidence, or product line expansion, the company profile is best characterized as a single-category DTC supplement brand with limited disclosed operational granularity.

Name

Atrantil

Website

https://atrantil.com

Company type

Private

Founded year

2015

Headcount range

11–50 employees

Short description

Atrantil is a Dallas-based, privately held manufacturer of digestive health supplements founded in 2015 by Kenneth Brown. The small (11-50 employees) founder-led company sells its products direct-to-consumer through its website.

Ownership category

akta.pro rank

Product category

Digestive Health Supplements

NAICS

Food (Health) Supplement Retailers (456191)

SIC

Food And Kindred Products (2000)

akta.pro primary industry

Probiotics & Digestive Health Supplements (CRADAGAF)

akta.pro secondary industry

Gut Health & Digestive Nutrition (IBS, GERD, Elimination Diets) (HSADAFAH)

Keywords

• Digestive supplements
• Gastrointestinal health
• Botanical supplements
• Gut health products
• Bloating relief

Headquarters

HQ city

Dallas

HQ country

United States

HQ region

North America

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Marketing or Sales, Personnel

Core offering

Atrantil manufactures and sells digestive supplement products formulated to support gastrointestinal health. The company produces physical supplement goods targeting gut-related conditions and is positioned as a small-scale manufacturer in the consumer wellness space.

Differentiator

Problem solved

Functional benefit

Products and services

• Digestive supplement products Digestive supplement products manufactured by Atrantil for consumers seeking gastrointestinal and gut health support, including relief from bloating.

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Broad incumbents

• Culturelle: Mass-market probiotic brand owned by i-Health. Competes with Atrantil on the consumer shelf for digestive complaints but at much broader scale and distribution.
• Florastor: Established digestive-health probiotic brand with broad consumer awareness. Overlaps with Atrantil's use cases (bloating, GI balance) at a wider retail footprint.
• Garden of Life: Large organic/natural supplements portfolio including probiotics and digestive enzymes. Competes with Atrantil across natural and practitioner channels.
• Thorne: Premium practitioner-grade supplements brand with a deep digestive/gut-health portfolio and strong DTC and practitioner channels. Comparable in premium clinical positioning, though broader in scope.

Direct peers

• Integrative Therapeutics: Practitioner-channel supplement brand with a dedicated gastrointestinal line. Comparable to Atrantil in formulation philosophy and clinical positioning.
• Pure Encapsulations: Professional-grade supplements including a deep digestive-health portfolio sold through practitioners. Comparable in clinical positioning and premium pricing strategy.
• Microbiome Labs: Direct competitor in the gut-health / SIBO-adjacent supplement category, offering practitioner-channel digestive and microbiome products. Most comparable peer to Atrantil in product positioning and target customer.
• Bio-Botanical Research: Maker of Biocidin and other practitioner-grade gut-dysbiosis formulas targeted at SIBO and related conditions. Directly overlaps Atrantil's clinical-niche positioning.
• Priority One Nutritional Supplements: Practitioner-channel supplement line with strong digestive and gut-health SKUs. Comparable in distribution model and customer base to Atrantil.
• Enzymedica: Specialty digestive health brand built on enzymes and gut-targeted formulations. Comparable in category focus and DTC-led go-to-market.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat2 records

Key risks4 records

Key highlights4 records

Customer concentration

• Xx.com/atrantil
• Facebookfacebook.com/Atrantil
• LinkedInlinkedin.com/company/atrantil

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Atrantil